EZH2 and colitis: The degradation of EZH2 results in the inhibition of H3K27me3 modification and increases the expression of CCL2 and CCL7 in CXCR1hi macrophages, subsequently promoting the recruitment of CX3CR1int pro-inflammatory mononuclear phagocytes (MPhs) into colitis-affected colon tissues.